WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) shares saw unusually-high trading volume on Tuesday . 2,496 shares were traded during trading, an increase of 18% from the previous session’s volume of 2,124 shares.The stock last traded at $22.87 and had previously closed at $21.61.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised WuXi AppTec to a “hold” rating in a report on Monday, April 13th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy”.
Get Our Latest Report on WuXi AppTec
WuXi AppTec Price Performance
WuXi AppTec Company Profile
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.
Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.
Featured Stories
- Five stocks we like better than WuXi AppTec
- Boeing’s Comeback Is Building Momentum—Is It Real?
- Blueprint for a Banking Fortress: Circle Redraws the Map
- Bed Bath & Beyond Renovates: The Neighborhood Blueprint
- These Outperforming Giants Are Boosting Dividends in 2026, With Yields of Up to 6.6%
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
